Question 24

A 46-year-old female patient with class 3 (BMI > 40kg/m2) obesity has been admitted to your ICU with community-acquired pneumonia. She is sedated and ventilated with no other organ dysfunction. You are considering starting nutritional therapy.

  • Outline the metabolic derangements likely to be present in this patient.
  • How would you make an assessment of this patient’s current nutritional status?
  • Outline your nutritional regimen in particular your optimal target protein and energy delivery.

[Click here to toggle visibility of the answers]

College Answer

A) A number of metabolic derangements affect fuel utilization:

  • Insulin resistance
  • Impaired glucose tolerance,
  • Increased fatty acid mobilization
  • Hyperlipidemia
  • Obese patients, compared to lean counterparts, may have accelerated protein degradation and depletion of lean body mass.
  • “Metabolic X syndrome” may exist: insulin resistance, hyperinsulinemia, hyperglycaemia, coronary artery disease, hypertension, and hyperlipidemia.
  • Obese patients are more likely to have a pre-existing pro inflammatory state.
  • Obese patients have increased resting energy expenditure secondary to increased BMI, with central adipose tissue being more metabolically active than peripheral adipose tissue.

b) Assessment

  • Assess patterns of weight change and nutrition intake prior to the admission
  • Anthropometrics –actual body weight, ideal body weight, usual body weight, height, BMI, and waist circumference should be determined
  • (Biomarkers of the metabolic syndrome; triglycerides, cholesterol, glucose serum albumin and pre-albumin)

c) Nutritional Regimen

• High protein (anabolic) hypocaloric feeding (reduced complications from overfeeding) should be provided to the obese critically ill patient regardless of whether the route of nutrition therapy is enteral or parenteral

  • Most studies using this method give 11-14 kcal/kg/actual BW per day or 22-25 kcal/kg IBW per day- equates to about 60-70% of calorie requirement determined by indirect calorimetry or predictive equation.
  • Protein requirements should be met to maximise protein synthesis and preserve lean body mass (> 2.0g/kg IBW/d for class 1 and 2 obesity and > 2.5g/kg IBW/d for class 3).


The spectrum of metabolic derangements present in the obese ICU patient is detailed elsewhere.  In short, these are the major metabolic abnormalities one can expect from an obese patient in the ICU:

  • Insulin resistance and impaired glucose tolerance
  • Increased fatty acid mobilization and hyperlipidemia
  • Accelerated protein degradation
  • The proinflammatory state of obesity
  • The endocrine derangements due to an excess of fatty tissue
  • The increased resting metabolic rate of obesity

Assessment of nutritional status is also detailed elsewhere; in brief the assessment takes the shaped of a structured approach, from history to investigatons:


  • Premorbid weight and the pattern of its change
  • Premorbid nutritional routine
  • Diseases affecting gastrointestinal function (eg. coeliac disease)
  • Disease affecting satiety control (eg. Prader-Willi syndrome)
  • Factors influencing metabolic substrate utilisation (eg. thyroid dysfunction, hypoadrenalism, Cushings disease or corticosteroid therapy)


  • Observed quality of nails and hair
  • Subcutaneous fat measurements (triceps)
  • Muscle bulk and muscle tone of quadriceps and deltoids
  • Presence of oedema and ascites


  • BMI
  • Ideal body weight
  • Lean body mass


  • Cholesterol and triglycerides
  • Random BSL
  • HbA1C
  • Serum cortisol
  • TFTs
  • Albumin and prealbumin

Nutrition for the obese ICU patient is presently a topic of hot debate. The most recent suggestions are summarised elsewhere. In short, the published consensus statements suggest we follow a certain pattern:

References is an excellent resource for all things nutrition-related.

Berger, Mette M., and Claude Pichard. "Best timing for energy provision during critical illness." Crit Care 16.2 (2012): 215.


Dhaliwal, Rupinder, et al. "The Canadian Critical Care Nutrition Guidelines in 2013 An Update on Current Recommendations and Implementation Strategies."Nutrition in Clinical Practice 29.1 (2014): 29-43.


de Souza Menezes, Fernanda, Heitor Pons Leite, and Paulo Cesar Koch Nogueira. "Malnutrition as an independent predictor of clinical outcome in critically ill children." Nutrition 28.3 (2012): 267-270.


Norman, Kristina, et al. "Prognostic impact of disease-related malnutrition."Clinical nutrition 27.1 (2008): 5-15.


Detsky, Allan S., et al. "What is subjective global assessment of nutritional status." JPEN J Parenter Enteral Nutr 11.1 (1987): 8-13.


Sauberlich, Howerde E. Laboratory tests for the assessment of nutritional status. Vol. 21. CrC Press, 1999.


Gorstein, Jonathan, et al. "Issues in the assessment of nutritional status using anthropometry." Bulletin of the World Health Organization 72.2 (1994): 273.


Shenkin, Alan. "Serum prealbumin: Is it a marker of nutritional status or of risk of malnutrition?." Clinical chemistry 52.12 (2006): 2177-2179.


Port, Ava M., and Caroline Apovian. "Metabolic support of the obese intensive care unit patient: a current perspective." Current opinion in clinical nutrition and metabolic care 13.2 (2010): 184.


McClave, Stephen A., et al. "Nutrition Therapy of the Severely Obese, Critically Ill Patient Summation of Conclusions and Recommendations." Journal of Parenteral and Enteral Nutrition 35.5 suppl (2011): 88S-96S.


Wichansawakun, Sanit, et al. "Metabolic Support of the Obese Intensive Care Unit Patient." Integrative Weight Management. Springer New York, 2014. 215-224.